For instance, the tobacco giant Philip Morris has even invested $20 million into Syqe Medical to support the development of technologies that help reduce smoking-associated health risks,” explained Gilmore.
Read more on PR Newswire here.
For instance, the tobacco giant Philip Morris has even invested $20 million into Syqe Medical to support the development of technologies that help reduce smoking-associated health risks,” explained Gilmore.
Read more on PR Newswire here.
![[CytoReason in NoCamels] cytoreason teams up with merck kgaa on cancer drug development](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
